Johnson & Johnson
JNJCompany Overview
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Shariah Compliance Benchmarks:
- Business Compliance: Non-Shariah compliant revenue must be less than 5% of total revenue
- Liabilities Compliance: Interest-bearing debt must be less than 33% of market capitalization
This stock meets all Shariah compliance criteria according to AAOIFI standards.
Name | Johnson & Johnson |
Ticker | JNJ |
Main Business | Drug Manufacturers—General |
Type | Common Stock |
Industry | Drug Manufacturers—General |
Country | US |
Market Cap | $377.74 B |
Shariah Analysis Breakdown
Revenue Segment | Value ($M) | Non-Compliant ($M) | Reason |
---|---|---|---|
Innovative Medicine | $52,560.0 | $0.0 | - |
MedTech | $27,430.0 | $0.0 | - |
Consumer Health | $14,950.0 | $0.0 | - |
Interest income | $490.0 | $490.0 | - |
Total | $95,430.0 | $490.0 | 0.51% (passed) |
Liability Item | Value ($M) | % of Market Cap |
---|---|---|
current debt and capital lease obligation | $3,450,000,000.0 | 0.91% |
long term debt and capital lease obligation | $25,880,000,000.0 | 6.85% |
Total Interest-Bearing Debt | $29,330,000,000.0 | 7.76% |
Market Capitalization | $377,743,400,000.0 | 100.00% |
Compliance Status | Threshold: 33% | passed |